Trial intelligence / Profile preview

NOP Receptors and Relapse in Alcoholism

NCT03448016Phase 1Completed

Start
May 2016
Primary completion
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of [11C]NOP-1A in alcohol use disorder (AUD) (2 arms). Primary endpoint: [C-11]NOP-1A Total Distribution Volume. Started May 2016; status: completed.

02

Drugs

[11C]NOP-1A
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT03448016.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03448016.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call